These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

736 related items for PubMed ID: 24687988

  • 61. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice.
    Nyström J, Raghavan S, Svennerholm AM.
    Microbes Infect; 2006 Feb; 8(2):442-9. PubMed ID: 16243563
    [Abstract] [Full Text] [Related]

  • 62. Recombinant antigen from Helicobacter pylori urease as vaccine against H. pylori-associated disease.
    Fujii R, Morihara F, Fukushima K, Oku T, Hifumi E, Uda T.
    Biotechnol Bioeng; 2004 Jun 30; 86(7):737-46. PubMed ID: 15162449
    [Abstract] [Full Text] [Related]

  • 63. Oral immunization with Helicobacter pylori-loaded poly(D, L-lactide-co-glycolide) nanoparticles.
    Kim SY, Doh HJ, Jang MH, Ha YJ, Chung SI, Park HJ.
    Helicobacter; 1999 Mar 30; 4(1):33-9. PubMed ID: 10352085
    [Abstract] [Full Text] [Related]

  • 64. Neutralizing antibodies for Helicobacter pylori urease inhibit bacterial colonization in the murine stomach in vivo.
    Takeshita H, Watanabe E, Norose Y, Ito Y, Takahashi H.
    Biomed Res; 2019 Mar 30; 40(2):87-95. PubMed ID: 30982804
    [Abstract] [Full Text] [Related]

  • 65. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
    Metzger WG, Mansouri E, Kronawitter M, Diescher S, Soerensen M, Hurwitz R, Bumann D, Aebischer T, Von Specht BU, Meyer TF.
    Vaccine; 2004 Jun 02; 22(17-18):2273-7. PubMed ID: 15149786
    [Abstract] [Full Text] [Related]

  • 66. Peroral immunization with Helicobacter pylori adhesin protein genetically linked to cholera toxin A2B subunits.
    Kim BO, Shin SS, Yoo YH, Pyo S.
    Clin Sci (Lond); 2001 Mar 02; 100(3):291-8. PubMed ID: 11222115
    [Abstract] [Full Text] [Related]

  • 67. Systemic immunization with urease protects mice against Helicobacter pylori infection.
    Guy B, Hessler C, Fourage S, Haensler J, Vialon-Lafay E, Rokbi B, Millet MJ.
    Vaccine; 1998 May 02; 16(8):850-6. PubMed ID: 9627943
    [Abstract] [Full Text] [Related]

  • 68. Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infection.
    Ghasemi A, Mohammad N, Mautner J, Taghipour Karsabet M, Amani J, Ardjmand A, Vakili Z.
    Vaccine; 2018 Aug 16; 36(34):5124-5132. PubMed ID: 30041879
    [Abstract] [Full Text] [Related]

  • 69. Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens.
    Keenan JI, Rijpkema SG, Durrani Z, Roake JA.
    FEMS Immunol Med Microbiol; 2003 May 25; 36(3):199-205. PubMed ID: 12738392
    [Abstract] [Full Text] [Related]

  • 70. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.
    Hadad R, Marks E, Kalbina I, Schön K, Unemo M, Lycke N, Strid Å, Andersson S.
    APMIS; 2016 Dec 25; 124(12):1078-1086. PubMed ID: 27859689
    [Abstract] [Full Text] [Related]

  • 71. Oral vaccination against Helicobacter pylori with recombinant cholera toxin B-subunit.
    Kubota E, Joh T, Tanida S, Sasaki M, Kataoka H, Watanabe K, Itoh K, Oshima T, Ogasawara N, Togawa S, Wada T, Yamada T, Mori Y, Fujita F, Shimura T, Ohara H, Isaka M, Yasuda Y, Itoh M.
    Helicobacter; 2005 Aug 25; 10(4):345-52. PubMed ID: 16104951
    [Abstract] [Full Text] [Related]

  • 72. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J, Adamsson J, Harandi AM.
    Scand J Immunol; 2008 May 25; 67(5):431-40. PubMed ID: 18298617
    [Abstract] [Full Text] [Related]

  • 73. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses.
    Ermak TH, Giannasca PJ, Nichols R, Myers GA, Nedrud J, Weltzin R, Lee CK, Kleanthous H, Monath TP.
    J Exp Med; 1998 Dec 21; 188(12):2277-88. PubMed ID: 9858514
    [Abstract] [Full Text] [Related]

  • 74. Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant.
    Holmgren J, Nordqvist S, Blomquist M, Jeverstam F, Lebens M, Raghavan S.
    Vaccine; 2018 Oct 01; 36(41):6223-6230. PubMed ID: 30119923
    [Abstract] [Full Text] [Related]

  • 75. Immunization with the immunodominant Helicobacter suis urease subunit B induces partial protection against H. suis infection in a mouse model.
    Vermoote M, Van Steendam K, Flahou B, Smet A, Pasmans F, Glibert P, Ducatelle R, Deforce D, Haesebrouck F.
    Vet Res; 2012 Oct 26; 43(1):72. PubMed ID: 23101660
    [Abstract] [Full Text] [Related]

  • 76. Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection.
    Weltzin R, Kleanthous H, Guirakhoo F, Monath TP, Lee CK.
    Vaccine; 1997 Mar 26; 15(4):370-6. PubMed ID: 9141207
    [Abstract] [Full Text] [Related]

  • 77. [Expression of helicobacter pylori alpA gene in lactococcus lactis and its immunogenicity analysis].
    Sun ZL, Bi YW, Bai CM, Gao DD, Li ZH, Dai ZX, Li JF, Xu WM.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Mar 26; 26(3):203-6. PubMed ID: 20230679
    [Abstract] [Full Text] [Related]

  • 78. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.
    Weltzin R, Guy B, Thomas WD, Giannasca PJ, Monath TP.
    Infect Immun; 2000 May 26; 68(5):2775-82. PubMed ID: 10768972
    [Abstract] [Full Text] [Related]

  • 79. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses.
    Nyström J, Svennerholm AM.
    Vaccine; 2007 Mar 30; 25(14):2591-8. PubMed ID: 17239498
    [Abstract] [Full Text] [Related]

  • 80. Screening and identification of a novel B-cell neutralizing epitope from Helicobacter pylori UreB.
    Li HX, Mao XH, Shi Y, Ma Y, Wu YN, Zhang WJ, Luo P, Yu S, Zhou WY, Guo Y, Wu C, Guo G, Zou QM.
    Vaccine; 2008 Dec 09; 26(52):6945-9. PubMed ID: 18948159
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.